STIFEL FINANCIAL CORP

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 720672 ST. LOUIS, MO

Position in CRNX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$793,302

+$28,477 QoQ

Shares Held

21,200

+0.7% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#135

of 264 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $537,727,692 across 104 Biotechnology names. CRNX ranks #54 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BHVN	Biohaven Ltd.	9,941,165	$147,924,534
2	VRTX	Vertex Pharmaceuticals Inc / Ma	162,151	$80,545,262
3	MANE	Veradermics, Inc	294,117	$36,158,743
4	JAZZ	Jazz Pharmaceuticals plc	139,491	$33,613,146
5	REGN	Regeneron Pharmaceuticals, Inc.	46,378	$28,918,535
6	OMER	Omeros Corp	1,836,925	$17,469,155
7	NTLA	Intellia Therapeutics, Inc.	1,014,387	$17,163,427
8	IONS	Ionis Pharmaceuticals Inc	202,983	$16,094,521

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$793,302	21,200	+0.7%	Shares	Defined	2026-08-12
2026-03-31	$764,825	21,058	-0.7%	Shares	Defined	2026-05-12
2025-12-31	$986,858	21,200	-2.5%	Shares	Defined	2026-02-13
2025-09-30	$905,177	21,733	+1.3%	Shares	Defined	2025-11-12
2025-06-30	$617,073	21,456	+138.5%	Shares	Defined	2025-08-14
2025-03-31	$301,792	8,998	-9.1%	Shares	Defined	2025-05-14
2024-12-31	$505,879	9,894	-1.4%	Shares	Defined	2025-02-13
2024-09-30	$512,941	10,038	-4.9%	Shares	Defined	2024-11-14
2024-06-30	$472,891	10,558	+3.4%	Shares	Defined	2024-08-13
2024-03-31	$478,022	10,212	—	Shares	Defined	2024-05-14
No filing history on record for this holder in this stock.